Cargando…

Viremia in human Cowpox virus infection

BACKGROUND: Several poxviruses can infect humans and cause diseases of varying severity. Besides the eradicated Variola virus that induced high mortality rates, numerous further human pathogenic orthopoxviruses are potentially fatal but generally cause less severe infections. While infection-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Nitsche, Andreas, Kurth, Andreas, Pauli, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528219/
https://www.ncbi.nlm.nih.gov/pubmed/17765007
http://dx.doi.org/10.1016/j.jcv.2007.07.014
_version_ 1784801262769799168
author Nitsche, Andreas
Kurth, Andreas
Pauli, Georg
author_facet Nitsche, Andreas
Kurth, Andreas
Pauli, Georg
author_sort Nitsche, Andreas
collection PubMed
description BACKGROUND: Several poxviruses can infect humans and cause diseases of varying severity. Besides the eradicated Variola virus that induced high mortality rates, numerous further human pathogenic orthopoxviruses are potentially fatal but generally cause less severe infections. While infection-related viremia was described for Variola virus and seems to be rare for Monkeypox virus, it is still debated for Vaccinia virus. So far, viremia in Cowpox virus-infected humans has not been reported. OBJECTIVES: To estimate the potential risk of Cowpox virus to disseminate and develop severe infections, two Cowpox virus patients were examined for viremia. STUDY DESIGN: Whole blood, serum and fluid from virus-induced lesions were analyzed by serology or quantitative real-time PCR. RESULTS: Real-time PCR and sequence analysis of the hemagglutinin gene confirmed Cowpox virus in the lesions of both patients. Serology performed on serum obtained at the same time as the lesion specimens demonstrated orthopoxvirus-specific IgG and IgM antibodies, indicating a recent orthopoxvirus infection. In addition, Cowpox virus DNA was detectable in whole blood, but not in serum, as late as week 4 post-infection. CONCLUSIONS: In contrast to observations following vaccination with Vaccinia virus, DNAemia in patients with localized symptoms of a Cowpox virus infection does not seem to be a rare event. However, its relevance for Cowpox virus pathogenicity has to be elucidated.
format Online
Article
Text
id pubmed-9528219
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-95282192022-10-07 Viremia in human Cowpox virus infection Nitsche, Andreas Kurth, Andreas Pauli, Georg J Clin Virol Short Communication BACKGROUND: Several poxviruses can infect humans and cause diseases of varying severity. Besides the eradicated Variola virus that induced high mortality rates, numerous further human pathogenic orthopoxviruses are potentially fatal but generally cause less severe infections. While infection-related viremia was described for Variola virus and seems to be rare for Monkeypox virus, it is still debated for Vaccinia virus. So far, viremia in Cowpox virus-infected humans has not been reported. OBJECTIVES: To estimate the potential risk of Cowpox virus to disseminate and develop severe infections, two Cowpox virus patients were examined for viremia. STUDY DESIGN: Whole blood, serum and fluid from virus-induced lesions were analyzed by serology or quantitative real-time PCR. RESULTS: Real-time PCR and sequence analysis of the hemagglutinin gene confirmed Cowpox virus in the lesions of both patients. Serology performed on serum obtained at the same time as the lesion specimens demonstrated orthopoxvirus-specific IgG and IgM antibodies, indicating a recent orthopoxvirus infection. In addition, Cowpox virus DNA was detectable in whole blood, but not in serum, as late as week 4 post-infection. CONCLUSIONS: In contrast to observations following vaccination with Vaccinia virus, DNAemia in patients with localized symptoms of a Cowpox virus infection does not seem to be a rare event. However, its relevance for Cowpox virus pathogenicity has to be elucidated. Elsevier B.V. 2007-10 2007-08-30 /pmc/articles/PMC9528219/ /pubmed/17765007 http://dx.doi.org/10.1016/j.jcv.2007.07.014 Text en Copyright © 2007 Elsevier B.V. All rights reserved. Elsevier has created a Monkeypox Information Center in response to the declared public health emergency of international concern, with free information in English on the monkeypox virus. The Monkeypox Information Center is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its monkeypox related research that is available on the Monkeypox Information Center - including this research content - immediately available in publicly funded repositories, with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the Monkeypox Information Center remains active.
spellingShingle Short Communication
Nitsche, Andreas
Kurth, Andreas
Pauli, Georg
Viremia in human Cowpox virus infection
title Viremia in human Cowpox virus infection
title_full Viremia in human Cowpox virus infection
title_fullStr Viremia in human Cowpox virus infection
title_full_unstemmed Viremia in human Cowpox virus infection
title_short Viremia in human Cowpox virus infection
title_sort viremia in human cowpox virus infection
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528219/
https://www.ncbi.nlm.nih.gov/pubmed/17765007
http://dx.doi.org/10.1016/j.jcv.2007.07.014
work_keys_str_mv AT nitscheandreas viremiainhumancowpoxvirusinfection
AT kurthandreas viremiainhumancowpoxvirusinfection
AT pauligeorg viremiainhumancowpoxvirusinfection